The T-type calcium channel as a new therapeutic target for Parkinson’s disease

By Yang Ya-Chin   Tai Chun-Hwei   Pan Ming-Kai   Kuo Chung-Chin  

Pflügers Archiv, Vol. 466, Iss. 4, 2014-04 ,pp. : 747-755

Springer Publishing Company

Access to resources Recommend Favorite

Electromyography Parameters of Muscular Fatigue and Recovery in Patients with Parkinson’s Disease before and on Medication

By Antonen E.   Meigal A.   Lupandin Yu.  

Human Physiology, Vol. 31, Iss. 4, 2005-07 ,pp. : 439-444

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Effect of Transcranial Magnetic Stimulation on Short- and Long-Term Memory in Healthy Subjects and Patients with Parkinson’s Disease

By Gimranov R.   Mal’tseva E.  

Human Physiology, Vol. 31, Iss. 4, 2005-07 ,pp. : 398-401

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Caught in the Act - -Synuclein Is the Culprit in Parkinson's Disease

By Eriksen J.L.   Dawson T.M.   Dickson D.W.   Petrucelli L.  

Neuron, Vol. 40, Iss. 3, 2003-10 ,pp. : 453-456

Elsevier

Access to resources Recommend Favorite

Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease

By Simon D.K.   Lin M.T.   Zheng L.   Liu G.-J.   Ahn C.H.   Kim L.M.   Mauck W.M.   Twu F.   Beal M.F.   Johns D.R.  

Neurobiology of Aging, Vol. 25, Iss. 1, 2004-01 ,pp. : 71-81

Elsevier

Access to resources Recommend Favorite